Scarring Alopecia – Friday Pop Quiz 2/10/2023
171221712217122
A 55 year-old woman comes in for a rash in her mouth pictured below. Also on exam, you note a scarring alopecia of the scalp. From the below options, which other location should you examine for hair loss?
A. Eyebrows
B. Legs
C. Axilla
D. Arms
E. Eyelashes
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
…
A 55 year-old woman comes in for a rash in her mouth pictured below. Also on exam, you note a scarring alopecia of the scalp. From the below options, which other location should you examine for hair loss?
A. Eyebrows
B. Legs
C. Axilla
D. Arms
E. Eyelashes
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
… Continue reading "Scarring Alopecia – Friday Pop Quiz 2/10/2023"
On this Mnemonic Monday, we challenge you to remember the geographical areas and associated species known for NEW WORLD leishmaniasis transmission with the following mnemonic:
Let's Go Get Brazilian Blowouts in Mexico
Let's = “lutz” aka Lutzomya sandfly species responsible for transmitting new world leishmaniasis
Brazilian = L. braziliensis complex, leishmaniasis species commonly … 
Hair loss can be such a challenging disease to treat, especially with the social toll it can take on patients. Do you struggle to keep up with the newest treatments and data on hair loss? If so, keep reading as we learn from Dr. Shilpi Khetarpal, Associate Professor of Dermatology and Director of Cosmetic Dermatology and Lasers at Cleveland Clinic, about adjunctive therapies for hair loss based on … 
Androgenic alopecia (AGA) is one of the most common forms of hair loss and represents a frequently faced disabling concern in dermatology visits. Targeting the 5α-dihydrotestosterone (DHT) pathway has been shown to be an efficacious mechanism of action, with finasteride being the only systemic FDA-approved drug to treat male AGA. Recently, its sister drug, dutasteride, has been increasingly utili … 
During the recent DERM2O22 NP/PA CME conference held July 28-31, 2022, Drs. David Cohen, Brad Glick, and Adam Friedman led a case-based panel discussion on atopic dermatitis (AD) treatment initiation and monitoring. This article provides a summary of their discussion and recommendations.
CASE 1
51-year-old male with a 20-year history of AD. The patient was first seen in September 2015 with BSA … 